Загрузка...
New approaches in the management of advanced breast cancer – role of combination treatment with liposomal doxorubicin
Metastatic breast cancer (MBC) remains a major cause of morbidity and mortality in women worldwide. For three decades doxorubicin, alone or in combination with other cytotoxic agents, has been a mainstay of systemic therapy for MBC. However, its use is limited by cumulative cardiotoxicity. More rece...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846637/ https://ncbi.nlm.nih.gov/pubmed/24367159 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|